Numerous studies have shown that upregulation of N-cadherin is significantly associated with lymph node metastases, histological grade, angiolymphatic invasion and clinical stage, suggesting that N-cadherin indicates an aggressive tumor and predicts poor survival [73]. The gene discussed is CDH2; the disease is neoplasm.